February 12, 2018 / 1:15 PM / 7 months ago

BRIEF-Catalyst Pharmaceuticals Announces Plans To Resubmit New Drug Application For Firdapse

1 分钟阅读

Feb 12 (Reuters) - Catalyst Pharmaceuticals Inc:

* CATALYST PHARMACEUTICALS ANNOUNCES PLANS TO RESUBMIT NEW DRUG APPLICATION FOR FIRDAPSE®

* CATALYST PHARMACEUTICALS - CURRENTLY ANTICIPATES RESUBMITTING NDA FOR FIRDAPSE FOR LEMS TO FDA BY END OF Q1 2018 Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below